C Cosmo Pharmaceuticals N.V.: insider trades · Switzerland · SIX SER SIX:cosmo-pharmaceuticals-nv NL0011832936 CH CH · SIX SER
Discover the full directors' dealings record of Cosmo Pharmaceuticals N.V., a listed issuer based in Switzerland. Shares are listed on CH CH, under the oversight of SIX SER. The latest transaction was filed on 9 March 2026 — Purchase. Among the most active insiders: Anonymous (Executive member of the board of directors / member of senior management). The full history is free.
Last declaration on 9 March 2026
Declarations 50 total
Executives ● Purchase0 SIX
€294,892 2,886 shares @ €102.1803 NL0011832936⌘
SIX:T1Q3900024 · 9 Mar 2026
Ideal exit: 4 Dec 2026 (T+270) Executives ● Sale0 SIX
€123,085 1,000 shares @ €123.0849 NL0011832936⌘
SIX:T1Q1L00069 · 21 Jan 2026
Executives ● Sale0 SIX
€235,415 2,000 shares @ €117.7076 NL0011832936⌘
SIX:T1Q1G00044 · 16 Jan 2026
Executives ● Sale0 SIX
€118,458 1,000 shares @ €118.458 NL0011832936⌘
SIX:T1Q1G00028 · 16 Jan 2026
Executives ● Sale0 SIX
€11,835 100 shares @ €118.3508 NL0011832936⌘
SIX:T1Q1G00010 · 16 Jan 2026
Executives ● Sale0 SIX
€115,088 1,000 shares @ €115.0881 NL0011832936⌘
SIX:T1Q1F00012 · 15 Jan 2026
Executives ● Sale0 SIX
€57,356 500 shares @ €114.7121 NL0011832936⌘
SIX:T1Q1E00064 · 14 Jan 2026
Executives ● Sale0 SIX
€57,034 500 shares @ €114.0689 NL0011832936⌘
SIX:T1Q1E00015 · 14 Jan 2026
Executives ● Sale0 SIX
€115,008 1,000 shares @ €115.008 NL0011832936⌘
SIX:T1Q1D00041 · 13 Jan 2026
Executives ● Sale0 SIX
€116,643 1,000 shares @ €116.6429 NL0011832936⌘
SIX:T1Q1700046 · 7 Jan 2026
Executives ● Sale0 SIX
€116,690 1,000 shares @ €116.69 NL0011832936⌘
SIX:T1Q1600022 · 6 Jan 2026
Executives ● Sale0 SIX
€17,857 155 shares @ €115.2086 NL0011832936⌘
SIX:T1Q1500024 · 5 Jan 2026
Executives ● Sale0 SIX
€199,779 1,750 shares @ €114.1592 NL0011832936⌘
SIX:T1PCU00087 · 30 Dec 2025
Executives ● Sale0 SIX
€57,163 500 shares @ €114.325 NL0011832936⌘
SIX:T1PCU00079 · 30 Dec 2025
Executives ● Sale0 SIX
€1,159 10 shares @ €115.8923 NL0011832936⌘
SIX:T1PCM00068 · 22 Dec 2025
Executives ● Purchase0 SIX
€150,904 1,755 shares @ €85.9852 NL0011832936⌘
SIX:T1PCI00082 · 18 Dec 2025
Ideal exit: 14 Sept 2026 (T+270) Executives ● Purchase0 SIX
€150,904 1,755 shares @ €85.9852 NL0011832936⌘
SIX:T1PCI00066 · 18 Dec 2025
Ideal exit: 14 Sept 2026 (T+270) Executives ● Purchase0 SIX
€40,241 468 shares @ €85.9852 NL0011832936⌘
SIX:T1PCI00074 · 18 Dec 2025
Ideal exit: 14 Sept 2026 (T+270) Executives ● Purchase0 SIX
€72,013 838 shares @ €85.9347 NL0011832936⌘
SIX:T1PCH00084 · 17 Dec 2025
Ideal exit: 13 Sept 2026 (T+270) Executives ● Purchase0 SIX
€46,577 542 shares @ €85.9347 NL0011832936⌘
SIX:T1PCH000A5 · 17 Dec 2025
Ideal exit: 13 Sept 2026 (T+270) Executives ● Purchase0 SIX
€4m 46,667 shares @ €85.8089 NL0011832936⌘
SIX:T1PCG00037 · 16 Dec 2025
Ideal exit: 12 Sept 2026 (T+270) Executives ● Sale0 SIX
€2m 19,000 shares @ €102.7402 NL0011832936⌘
SIX:T1PCC00051 · 12 Dec 2025
Executives ● Sale0 SIX
€3m 27,500 shares @ €102.819 NL0011832936⌘
SIX:T1PCB00079 · 11 Dec 2025
Executives ● Sale0 SIX
€86,897 838 shares @ €103.6956 NL0011832936⌘
SIX:T1PCB00087 · 11 Dec 2025
Executives ● Purchase0 SIX
€254,028 4,163 shares @ €61.0204 NL0011832936⌘
SIX:T1PCA000J3 · 10 Dec 2025
Ideal exit: 6 Sept 2026 (T+270) 25 of 50 declarations
Load more (25 remaining)